Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Akebia Therapeutics Inc (NASDAQ: AKBA) was $3.58 for the day, up 0.56% from the previous closing price of $3.56. In other words, the price has increased by $0.56 from its previous closing price. On the day, 3.53 million shares were traded.
Ratios:
Our analysis of AKBA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.23. In the meantime, Its Debt-to-Equity ratio is 8.39 whereas as Long-Term Debt/Eq ratio is at 7.41.
On April 28, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On April 01, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $6.Jefferies initiated its Buy rating on April 01, 2025, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 09 ’25 when Malabre Richard C sold 15,000 shares for $4.01 per share. The transaction valued at 60,150 led to the insider holds 266,914 shares of the business.
Malabre Richard C sold 13,334 shares of AKBA for $47,069 on Jun 04 ’25. The SVP, Chief Accounting Officer now owns 266,914 shares after completing the transaction at $3.53 per share. On Mar 03 ’25, another insider, Butler John P., who serves as the CEO and President of the company, sold 46,409 shares for $1.83 each. As a result, the insider received 84,928 and left with 2,557,921 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.08 while its Price-to-Book (P/B) ratio in mrq is 38.11.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $4.08, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 35.73%, while the 200-Day Moving Average is calculated to be 77.50%.
Shares Statistics:
A total of 261.64M shares are outstanding, with a floating share count of 251.57M. Insiders hold about 4.21% of the company’s shares, while institutions hold 36.53% stake in the company.
